0.7536
price down icon1.58%   -0.0121
pre-market  プレマーケット:  .73   -0.0236   -3.13%
loading

Xilio Therapeutics Inc (XLO) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
175.90%
8.084
2.93 1.724 2.263 2.357
Operating Expenses
33.78%
22.45
16.78 15.35 17.02 17.06
Benefits Costs and Expenses
100.00%
-
16.20 14.82 - -
Costs And Expenses
38.62%
22.45
16.20 14.82 17.02 17.06
Operating Income/Loss
3.72%
-14.37
-13.85 -13.63 -14.76 -14.70
Nonoperating Income/Loss
352.22%
-1.478
0.586 0.536 0.742 0.779
Income/Loss From Continuing Operations Before Tax
160.94%
8.084
-13.27 -13.09 2.263 2.357
Income/Loss From Continuing Operations After Tax
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Net Income/Loss
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
29.11%
96.45
74.70 3.7486 63.47 57.76
Basic Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Diluted Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.64
price up icon 0.62%
$84.80
price up icon 1.07%
$28.08
price down icon 0.57%
$98.15
price down icon 1.12%
$144.78
price up icon 0.02%
biotechnology ONC
$332.20
price up icon 1.53%
大文字化:     |  ボリューム (24 時間):